Status:
COMPLETED
Impact of a Structural Phonation Training on Respiratory Muscle Function in Patients With Structural Heart Disease
Lead Sponsor:
University Hospital, Basel, Switzerland
Conditions:
Heart Failure
Congenital Heart Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Most patients with complex congenital heart disease and cardiomyopathy from acquired heart disease have reduced exercise capacity. Exercise capacity is associated with respiratory muscle strength and ...
Detailed Description
Most patients with complex congenital heart disease and cardiomyopathy from acquired heart disease have reduced exercise capacity (VO2 max). Furthermore, exercise capacity is associated with respirato...
Eligibility Criteria
Inclusion
- Informed Consent as documented by signature (Appendix Informed Consent Form)
- age ≥ 18 years
- known cardiomyopathy from acquired heart disease (ischemic or dilated) or patients with complex CHD (cyanotic congenital heart disease, Fontan palliation, subaortic right ventricle or repaired tetralogy of Fallot)
Exclusion
- Acute coronary syndrome, cardiac surgery or heart failure hospitalization within the previous 6 months
- chronic metabolic, orthopedic, or infectious disease; treatment with steroids, hormones, or cancer chemotherapy
- severe exercise-induced asthma
- professional singer or professionally performing a wind instrument
- Known or suspected non-compliance, drug or alcohol abuse
- Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant,
Key Trial Info
Start Date :
February 15 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 10 2018
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT03297918
Start Date
February 15 2018
End Date
October 10 2018
Last Update
October 11 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Basel
Basel, Switzerland, 4031